Annette M. Staiger

Annette M. Staiger

Dr. Margarete Fischer Bosch Institute Of Clinical Pharmacology
Stuttgart, BW 70376, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

AI for prognostic assessment of diffuse large B-cell lymphoma using H&E whole-slide images.

AI for prognostic assessment of diffuse large B-cell lymphoma using H&E whole-slide images.

Journal: HemaSphere

Published: April 08, 2026

Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis.

Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis.

Journal: Cancers

Published: December 30, 2025

Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models.

Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse Models.

Journal: International journal of molecular sciences

Published: October 16, 2025

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma.

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma.

Journal: Journal of visualized experiments : JoVE

Published: September 29, 2025

Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Journal: Blood advances

Published: April 21, 2025

Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP.

Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP.

Journal: Blood advances

Published: April 21, 2025

Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Journal: Blood advances

Published: April 21, 2025

The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential.

The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential.

Journal: Blood advances

Published: February 10, 2025

Pathogenesis of diffuse large B cell lymphoma proteogenotypes.

Pathogenesis of diffuse large B cell lymphoma proteogenotypes.

Journal: Cancer cell

Published: December 03, 2024

Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.

Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.

Journal: Leukemia

Published: November 18, 2024

MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q Aberration.

MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q Aberration.

Journal: Genes, chromosomes & cancer

Published: November 11, 2024

Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLA.

Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLA.

Journal: HemaSphere

Published: August 12, 2024

Showing 1-12 of 63

Last Updated: 09/26/2026